| 12234240 |
Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer |
Paul J. Hergenrother, Riley L. SVEC |
2025-02-25 |
| 11926877 |
Saliva-based molecular testing for SARS-CoV-2 |
Diana Rose Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang +3 more |
2024-03-12 |
| 11844798 |
Procaspase combination therapy for glioblastoma |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more |
2023-12-19 |
| 11833147 |
Procaspase 3 activation by combination therapy |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more |
2023-12-05 |
| 11530457 |
Saliva-based molecular testing for SARS-CoV-2 |
Diana Rose Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang +3 more |
2022-12-20 |
| 10888560 |
Procaspase 3 activation by combination therapy |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more |
2021-01-12 |
| 10874666 |
Procaspase combination therapy for glioblastoma |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more |
2020-12-29 |
| 10085978 |
Procaspase combination therapy for glioblastoma |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more |
2018-10-02 |
| 10085977 |
Procaspase 3 activation by combination therapy |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more |
2018-10-02 |
| 9643960 |
Procaspase activating compounds |
Paul J. Hergenrother, Quinn P. Peterson, Danny Chung Hsu, Diana C. West, Chris J. Novotny |
2017-05-09 |
| 9592229 |
Potent anticancer activity via dual compound activation |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Theodore M. Tarasow |
2017-03-14 |
| 9421202 |
Procaspase combination therapy for glioblastoma |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael J. Handley, Avadhut Joshi +2 more |
2016-08-23 |
| 9399035 |
Procaspase 3 activation by combination therapy |
Paul J. Hergenrother, Rachel C. Botham, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more |
2016-07-26 |
| 9102661 |
Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs |
Paul J. Hergenrother, Quinn P. Peterson, Danny Chung Hsu, Diana C. West, Chris J. Novotny |
2015-08-11 |
| 8778945 |
Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs |
Paul J. Hergenrother, Quinn P. Peterson, Danny Chung Hsu, Diana C. West, Chris J. Novotny |
2014-07-15 |
